Table 2.
Index cases | Matched controls | First-degree relatives, any cancer at ages 0–18 |
||||||
---|---|---|---|---|---|---|---|---|
Relatives of cases |
Relatives of controls |
|||||||
Diagnosed | Undiagnosed | Diagnosed | Undiagnosed | |||||
N | N | OR (95% CI) | p | |||||
Cancer of pediatric case | ||||||||
Any cancer, ages 0–4 | 1,552 | 7,760 | 32 | 6,226 | 52 | 33,460 | 3.6 (2.3–5.5) | <10–7 |
Any cancer, ages 0–18 | 4,482 | 22,410 | 49 | 18,476 | 148 | 102,803 | 2.0 (1.4–2.7) | <10–4 |
ICCC-3 classification, ages 0–18 | ||||||||
Leukemias, myeloproliferative | 1,150 | 5,750 | 12 | 4,455 | 33 | 25,615 | 2.3 (1.2–4.6) | 0.01 |
CNS and intracranial/intraspinal | 870 | 4,350 | 20 | 3,607 | 29 | 19,843 | 4.6 (2.6–8.1) | <10–6 |
Lymphomas, reticuloendothelial | 578 | 2,890 | 4 | 2,426 | 25 | 14,060 | 1.0 (0.4–2.9) | 0.99 |
Other epithelial and melanomas | 480 | 2,400 | 9 | 2,172 | 24 | 11,344 | 2.0 (0.9–4.3) | 0.08 |
Soft tissue, other sarcomas | 304 | 1,520 | 3 | 1,205 | 12 | 6,993 | 1.7 (0.5–6.2) | 0.39 |
Malignant bone tumors | 258 | 1,290 | 6 | 1,047 | 10 | 6,340 | 4.7 (1.7–13.0) | <0.01 |
Neuroblastoma, nervous cell | 254 | 1,270 | 3 | 1,030 | 11 | 5,750 | 1.8 (0.5–6.3) | 0.38 |
Germ cell tumors | 262 | 1,310 | 2 | 1,118 | 7 | 5,996 | 1.5 (0.3–7.3) | 0.60 |
Renal tumors | 203 | 1,015 | 6 | 897 | 0 | 4,989 | Undetermined | – |
Retinoblastomas | 87 | 435 | 2 | 347 | 2 | 1,928 | 5.7 (0.8–39.0) | 0.08 |
Hepatic tumors | 60 | 300 | 0 | 235 | 1 | 1,231 | Undetermined | – |
Cases compared to controls matched 5:1 on sex, birth year and birthplace (in Utah or outside of Utah).
Abbreviations: OR: odds ratio from conditional logistic regression; ICCC-3: International Classification of Childhood Cancer, Third edition13; CNS: central nervous system.